A coalition of Polish patient and consumer organizations is appealing to the Ministry of Health for guaranteed access to clear and comprehensive drug pricing information.
Patients Demand Access to Drug Prices
Patients are increasingly frustrated with the rising costs of treatment and a lack of clarity regarding the most affordable options for prescription fulfillment. A coalition of patient and consumer organizations is responding by appealing to the Ministry of Health.
Polish patients largely cover healthcare costs out-of-pocket. While price variations between pharmacies are common in a free market economy, finding the best deals can be a significant barrier, especially for those with chronic illnesses or multiple prescriptions.
Challenges Faced by Vulnerable Patients
Seniors, people with disabilities, and those with limited mobility often struggle to physically visit multiple pharmacies to compare prices, potentially leading them to forgo necessary treatments due to financial constraints.
Specific Demands of the Organizations
The organizations are requesting clear and predictable regulations that would require pharmacies to publicly display the actual prices of medications and medical products. They also seek to ensure easy access to information regarding product availability, opening hours, and prescription fulfillment capabilities.
The appeal also emphasizes the importance of transparency regarding pharmaceutical care services, such as medication reviews and vaccinations, particularly in smaller communities where pharmacies often serve as the primary point of healthcare access.
Distinguishing Ethical Support from Aggressive Marketing
The organizations stress the need to differentiate between aggressive marketing tactics and genuine financial assistance for patients. They support banning harmful advertising practices but also emphasize that transparent discounts and support programs, such as those linked to the Large Family Card or the National Senior Card, should not be viewed as a threat.
These programs offer real cost reductions and support patients without encouraging unnecessary consumption. The appeal has been sent to key government officials, including the Prime Minister, the Patient Rights Ombudsman, and members of the parliamentary health committees.